← All stories
Markets
AstraZeneca hit by lung cancer drug setback: Pharma giant halts trials of experimental Volrustomig treatment
Astra said its Volrustomig treatment, when combined with chemotherapy, was unlikely to help lung cancer patients live longer than rival offerings.
Covered by 1 outlet
All coverage · 1 article